Novel, potent, orally bioavailable and selective mycobacterial ATP synthase inhibitors that demonstrated activity against both replicating and non-replicating M. tuberculosis-Reference-Cited by-同舟云学术

Novel, potent, orally bioavailable and selective mycobacterial ATP synthase inhibitors that demonstrated activity against both replicating and non-replicating M. tuberculosis

Published:2015-02 Issue:4 Volume:23 Page:742-752
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Singh Supriya,Roy Kuldeep K.,Khan Shaheb R.,Kashyap Vivek Kr.,Sharma Abhisheak,Jaiswal Swati,Sharma Sandeep K.,Krishnan Manju Yasoda,Chaturvedi Vineeta,Lal Jawahar,Sinha Sudhir,Dasgupta Arunava,Srivastava Ranjana,Saxena Anil K.

Funder

CSIR

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference26 articles.

1. World Health Organization. Global Tuberculosis Report. WHO Report 2013; WHO Press: Geneva, Switzerland, 2013.

2. The challenge of new drug discovery for tuberculosis

3. Totally Drug-Resistant and Extremely Drug-Resistant Tuberculosis: The Same Disease?

4. MDR, XDR, TDR tuberculosis: ominous progression

5. Totally Drug-Resistant Tuberculosis in India

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. N-Acyl phenothiazines as mycobacterial ATP synthase inhibitors: Rational design, synthesis and in vitro evaluation against drug sensitive, RR and MDR-TB;Bioorganic Chemistry;2024-10

2. Deciphering insights into the binding mechanism and plasticity of Telacebec with M. tuberculosis cytochrome bcc-aa3 supercomplex through an unbiased molecular dynamics simulation, free-energy analysis, and DFT study;Journal of Biomolecular Structure and Dynamics;2023-12-18

3. A dual-targeting succinate dehydrogenase and F1Fo-ATP synthase inhibitor rapidly sterilizes replicating and non-replicating Mycobacterium tuberculosis;Cell Chemical Biology;2023-12

4. An update on ATP synthase inhibitors: A unique target for drug development in M. tuberculosis;Progress in Biophysics and Molecular Biology;2023-07

5. Molecular docking-based interaction studies on imidazo[1,2-a] pyridine ethers and squaramides as anti-tubercular agents;SAR and QSAR in Environmental Research;2023-06-03